COSMA S P A has a total of 29 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 1998. It filed its patents most often in EPO (European Patent Office), Italy and United States. Its main competitors in its focus markets organic fine chemistry, pharmaceuticals and surface technology and coating are HARMAN FINOCHEM LTD, APSINTERM LLC and ESWARAIAH SAJJA.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 9 | |
#2 | Italy | 7 | |
#3 | United States | 6 | |
#4 | Canada | 2 | |
#5 | Israel | 2 | |
#6 | WIPO (World Intellectual Property Organization) | 2 | |
#7 | China | 1 |
# | Industry | |
---|---|---|
#1 | Organic fine chemistry | |
#2 | Pharmaceuticals | |
#3 | Surface technology and coating | |
#4 | Machines |
# | Technology | |
---|---|---|
#1 | Heterocyclic compounds | |
#2 | Acyclic or carbocyclic compounds | |
#3 | Therapeutic chemical compounds | |
#4 | Organic chemistry methods | |
#5 | Centrifuges | |
#6 | Medical preparations | |
#7 | Metal enamelling |
# | Name | Total Patents |
---|---|---|
#1 | Lussana Massimiliano | 15 |
#2 | Pizzatti Enrica | 14 |
#3 | Baretti Sergio | 8 |
#4 | Vigano' Enrico | 8 |
#5 | Rainoni Mauro | 7 |
#6 | Celestini Paolo | 6 |
#7 | Landonio Ernesto | 5 |
#8 | Gambuzza Filippo | 4 |
#9 | Bertolotti Chiara | 3 |
#10 | Lanfranconi Simona | 1 |
Publication | Filing date | Title |
---|---|---|
EP3609877A1 | Process for the synthesis of firocoxib | |
EP2805936A1 | Process for preparing levomilnacipran HCL | |
WO2010069397A1 | Process for the preparation of diclofenac epolamine | |
US2008306296A1 | Process for the resolution of racemic verapamil | |
EP2019096A1 | Process for obtaining Cetirizine dihydrochloride | |
EP1900435A1 | System for controlling the environmental emissions during the discharge step in centrifuges | |
EP1767668A1 | Method for enamelling cast parts of standard hypoeutectic gray iron | |
EP1614677A2 | Improved procedure for the synthesis of bicalutamide | |
IL159514D0 | A new process for the synthesis of torsemide, in particular of pure and stable form ii | |
CA2423550A1 | Pharmaceutical compositions comprising 1-isopropyl-3-[(4-m-toluidino-3-pyridyl)sulphonyl]-urea as active ingredient |